NO972506L - Salter av 3-(2-(4(-amino-imino-metyl)-fenyl)-4-metyl-2,5-diokso-imidazolidin-1-yl(-acetylamino)-3-fenyl-propionsyre-etylestere - Google Patents
Salter av 3-(2-(4(-amino-imino-metyl)-fenyl)-4-metyl-2,5-diokso-imidazolidin-1-yl(-acetylamino)-3-fenyl-propionsyre-etylestereInfo
- Publication number
- NO972506L NO972506L NO972506A NO972506A NO972506L NO 972506 L NO972506 L NO 972506L NO 972506 A NO972506 A NO 972506A NO 972506 A NO972506 A NO 972506A NO 972506 L NO972506 L NO 972506L
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- methyl
- imidazolidin
- acetylamino
- dioxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19622489A DE19622489A1 (de) | 1996-06-05 | 1996-06-05 | Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters |
Publications (3)
Publication Number | Publication Date |
---|---|
NO972506D0 NO972506D0 (no) | 1997-06-02 |
NO972506L true NO972506L (no) | 1997-12-08 |
NO307999B1 NO307999B1 (no) | 2000-07-03 |
Family
ID=7796165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO972506A NO307999B1 (no) | 1996-06-05 | 1997-06-02 | Salter av 3-(2-(4-(4-amino-imino-metyl)-fenyl)-4-metyl-2,5- diokso-imidazolidin-1-yl(-acetylamino)-3-fenyl-propionsyre- etylestere, anvendelse av forbindelsene samt farmasøytiske preparater inneholdende disse |
Country Status (24)
Country | Link |
---|---|
US (1) | US6294562B1 (no) |
EP (1) | EP0811616B1 (no) |
JP (1) | JP4249277B2 (no) |
KR (1) | KR980002029A (no) |
CN (1) | CN1104420C (no) |
AR (1) | AR008993A1 (no) |
AT (1) | ATE294783T1 (no) |
AU (1) | AU717106B2 (no) |
BR (1) | BR9703459A (no) |
CA (1) | CA2206748C (no) |
CZ (1) | CZ292672B6 (no) |
DE (2) | DE19622489A1 (no) |
ES (1) | ES2241016T3 (no) |
HK (1) | HK1006359A1 (no) |
HR (1) | HRP970309B1 (no) |
HU (1) | HUP9700998A3 (no) |
IL (1) | IL120984A (no) |
MX (1) | MX9704128A (no) |
NO (1) | NO307999B1 (no) |
PL (1) | PL320355A1 (no) |
RU (1) | RU2174119C2 (no) |
SK (1) | SK70897A3 (no) |
TR (1) | TR199700457A2 (no) |
ZA (1) | ZA974912B (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19647380A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Ag | 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
US7544681B2 (en) | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
CA2540639C (en) * | 2003-10-02 | 2010-08-31 | Pharmacia & Upjohn Company Llc | Salts and polymorphs of a pyrrole-substituted indolinone compound |
EP1888120B1 (en) * | 2005-06-07 | 2012-12-05 | Ramot at Tel Aviv University Ltd. | Novel salts of conjugated psychotropic drugs and processes of preparing same |
US8222296B2 (en) | 2006-07-17 | 2012-07-17 | Ramot At Tel-Aviv University Ltd. | Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders |
WO2009101616A1 (en) | 2008-02-11 | 2009-08-20 | Ramot At Tel Aviv University Ltd. | Novel conjugates for treating neurodegenerative diseases and disorders |
CA2782514A1 (en) | 2009-12-09 | 2011-06-16 | Biolinerx Ltd. | Methods of improving cognitive functions |
JP2013520488A (ja) | 2010-02-24 | 2013-06-06 | ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド | ペルフェナジン−gabaのトリメシラート塩の結晶性形態物及びその製法方法 |
WO2012038963A1 (en) | 2010-09-22 | 2012-03-29 | Ramot At Tel-Aviv University Ltd. | An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same |
AR114489A1 (es) * | 2018-04-12 | 2020-09-09 | Morphic Therapeutic Inc | ANTAGONISTAS DE LA INTEGRINA a4b7 HUMANA |
MX2022004406A (es) | 2019-10-16 | 2022-08-25 | Morphic Therapeutic Inc | INHIBICIÓN DE INTEGRINA A4ß7 HUMANA. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4126277A1 (de) * | 1991-08-08 | 1993-02-11 | Cassella Ag | Hydantoinderivate |
DE4213634A1 (de) * | 1992-04-24 | 1993-10-28 | Cassella Ag | 2,4-Dioxo-imidazolidin-Derivate |
DE4224414A1 (de) | 1992-07-24 | 1994-01-27 | Cassella Ag | Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung |
DE4308034A1 (de) | 1993-03-13 | 1994-09-15 | Cassella Ag | Neue Heterocyclen, ihre Herstellung und ihre Verwendung |
DE4309867A1 (de) | 1993-03-26 | 1994-09-29 | Cassella Ag | Neue Harnstoffderivate, ihre Herstellung und Verwendung |
DE4427979A1 (de) | 1993-11-15 | 1996-02-15 | Cassella Ag | Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung |
DE19515177A1 (de) * | 1995-04-28 | 1996-10-31 | Cassella Ag | Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe |
-
1996
- 1996-06-05 DE DE19622489A patent/DE19622489A1/de not_active Withdrawn
-
1997
- 1997-05-28 ES ES97108569T patent/ES2241016T3/es not_active Expired - Lifetime
- 1997-05-28 EP EP97108569A patent/EP0811616B1/de not_active Expired - Lifetime
- 1997-05-28 DE DE59712294T patent/DE59712294D1/de not_active Expired - Lifetime
- 1997-05-28 AT AT97108569T patent/ATE294783T1/de not_active IP Right Cessation
- 1997-06-02 NO NO972506A patent/NO307999B1/no not_active IP Right Cessation
- 1997-06-03 IL IL12098497A patent/IL120984A/xx not_active IP Right Cessation
- 1997-06-03 JP JP14561797A patent/JP4249277B2/ja not_active Expired - Fee Related
- 1997-06-03 TR TR97/00457A patent/TR199700457A2/xx unknown
- 1997-06-03 CN CN97105465A patent/CN1104420C/zh not_active Expired - Fee Related
- 1997-06-03 AU AU24674/97A patent/AU717106B2/en not_active Ceased
- 1997-06-03 AR ARP970102405A patent/AR008993A1/es unknown
- 1997-06-04 HU HU9700998A patent/HUP9700998A3/hu unknown
- 1997-06-04 ZA ZA9704912A patent/ZA974912B/xx unknown
- 1997-06-04 PL PL97320355A patent/PL320355A1/xx unknown
- 1997-06-04 MX MX9704128A patent/MX9704128A/es not_active IP Right Cessation
- 1997-06-04 HR HR970309A patent/HRP970309B1/xx not_active IP Right Cessation
- 1997-06-04 CA CA002206748A patent/CA2206748C/en not_active Expired - Fee Related
- 1997-06-04 CZ CZ19971729A patent/CZ292672B6/cs unknown
- 1997-06-04 KR KR1019970022995A patent/KR980002029A/ko not_active Application Discontinuation
- 1997-06-04 SK SK708-97A patent/SK70897A3/sk unknown
- 1997-06-05 RU RU97109041/04A patent/RU2174119C2/ru not_active IP Right Cessation
- 1997-06-05 BR BR9703459A patent/BR9703459A/pt not_active IP Right Cessation
-
1998
- 1998-06-18 HK HK98105621A patent/HK1006359A1/xx not_active IP Right Cessation
-
1999
- 1999-04-29 US US09/301,907 patent/US6294562B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200000659A (et) | 4-(3,5-bis-trifluorometüülbensüülamino)-2-etüül-6-trifluorometüül-3,4-dihüdro-2H-kin oliin-1-karboksüülhappe etüülestrid või nende soolad ja valmistamise meetodid | |
NO972506L (no) | Salter av 3-(2-(4(-amino-imino-metyl)-fenyl)-4-metyl-2,5-diokso-imidazolidin-1-yl(-acetylamino)-3-fenyl-propionsyre-etylestere | |
DE59700915D1 (de) | Stabilisierter Milchsäurementhylester | |
NO982332D0 (no) | Salter av kinolin-derivater som NK3 antagonister | |
DE59709030D1 (de) | Verwendung von Reinigungsmitteln enthaltend 3-(N-Butylacetamino)-propionsäureethylester als insektiziden Wirstoff. | |
EE9700186A (et) | Klavulaanhappe soolad | |
NO20003960D0 (no) | Salter av paroksetin | |
DE69216979D1 (de) | 3-(unsubstituiertes oder substituiertes Benzyl)-1-Alkyl- 2-oxocyclopentancarbonsäurealkylesterderivate, und ihre Herstellung und ihre Anwendung | |
DK0888340T3 (da) | 4-(benzo-1,3-dioxolyl)-pyrrolidin-3-carboxylsyre-derivater som antagonister for enodthelin | |
NO975296D0 (no) | Fremgangsmåte for fremstilling av karboksylsyrederivater | |
EP0673914A3 (en) | Preparation of alpha-keto acid esters. | |
NO992225D0 (no) | FremgangsmÕte for fremstilling av salter og estere av klavulansyre | |
FR2687667B1 (fr) | Esters d'acides carboxyliques d'hydroxyphenylalcanols comme stabilisants. | |
TR199501675A2 (tr) | Klavulanik asid tuzlari. | |
DE59706245D1 (de) | Verwendung von milchsäureestern | |
PL316303A1 (en) | Derivatives of 2-(4-pyrazplyloxy-pyrimidin-5yl)-acetic acid | |
NO953322L (no) | Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler | |
DE60010725T2 (de) | Herstellung von arylcarbonsäureestern | |
NO963218L (no) | Para-hydroksyfenyleddiksyre for reduksjon av frastötningsevnen av insekticider | |
NO995841D0 (no) | Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2-fenylpropionsyre-derivater | |
DE69809692D1 (de) | Herstellung von Carbonsäureestern | |
IT1282289B1 (it) | 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare, | |
AU5755798A (en) | Use of 3-(n-butyl-acetamino)-ethyl propionate for improving the photostability of cinnamic acid derivatives | |
PL312075A1 (en) | Novel esters being derivatives of 3-(5-methylfuryl)-propan-1-ol | |
LV12147A (lv) | 2-Okso-4-fenilbutanskabes etilestera sinteze no 2,2-dietoksi-4-fenilbutenskabes etilestera |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |